| Withdrawn | Study to Evaluate the Pharmacodynamics and Safety of HGS1025 in Patients With Ulcerative Colitis Ulcerative Colitis | Phase 1 | 2011-12-01 |
| Completed | Study of Belimumab Administered Subcutaneously to Healthy Subjects Healthy | Phase 1 | 2011-02-01 |
| Terminated | A Study of HGS1029 in Subjects With Relapsed or Refractory Lymphoid Malignancies Lymphoid Malignancies | Phase 1 | 2009-10-01 |
| Terminated | Phase 2 Study of Belimumab Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus (SLE) Systemic Lupus Erythematosus | Phase 2 | 2008-10-01 |
| Completed | A Study of HGS1029 (AEG40826-2HCl) in Subjects With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2008-05-01 |
| Completed | A Study to Evaluate the Safety and Tolerability of Raxibacumab in Healthy Subjects Healthy | Phase 3 | 2008-03-01 |
| Completed | An Open-label, Nonrandomized Study to Evaluate the Safety and Immunogenicity of Raxibacumab With Reinjection Therapeutic Treatment of Inhalation Anthrax | Phase 2 / Phase 3 | 2008-01-31 |
| Completed | A Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE) Systemic Lupus Erythematosus | Phase 3 | 2007-05-01 |
| Completed | Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Chronic Hepatitis C | Phase 3 | 2007-02-01 |
| Completed | A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Can Non Small Cell Lung Cancer | Phase 2 | 2007-01-01 |
| Completed | Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naiv Chronic Hepatitis C | Phase 3 | 2006-12-01 |
| Completed | A Study of Belimumab in Subjects With Systemic Lupus Erythematosus Systemic Lupus Erythematosus | Phase 3 | 2006-12-01 |
| Completed | Study of Mapatumumab in Combination With Bortezomib (Velcade) and Bortezomib Alone in Subjects With Relapsed o Multiple Myeloma | Phase 2 | 2006-05-01 |
| Completed | A Study of Albuferon With Ribavirin in Interferon Alfa Naive Subjects With Chronic Hepatitis C Genotype 2 or 3 Chronic Hepatitis C | Phase 2 | 2005-11-01 |
| Completed | A Study of Albuferon and Ribavirin in Interferon Naive Subjects With Chronic Hepatitis C Genotype 1 Hepatitis C, Chronic | Phase 2 | 2005-05-01 |
| Completed | Safety and Efficacy of an Antibody to CCR5 in Individuals With HIV Who Are Not Currently on Antiretroviral The HIV Infections | Phase 1 | 2005-04-01 |
| Terminated | A Continuation Trial for Subjects With Rheumatoid Arthritis That Have Completed Protocol LBRA01 Rheumatoid Arthritis | Phase 2 | 2005-01-01 |
| Completed | A Study of Albuferon With Ribavirin in Interferon Treatment Experienced Subjects With Chronic Hepatitis C Hepatitis C | Phase 2 | 2004-10-01 |
| Completed | Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma ( Lymphoma, Non-Hodgkin | Phase 2 | 2004-06-01 |
| Completed | A Safety and Efficacy Study of LymphoStat-B™ (Monoclonal Anti-BLyS Antibody) in Subjects With Rheumatoid Arthr Arthritis, Rheumatoid | Phase 2 | 2003-12-01 |
| Completed | Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE) Lupus Erythematosus, Systemic | Phase 2 | 2003-10-01 |
| Completed | Phase 1 Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE) Systemic Lupus Erythematosus | Phase 1 | 2002-02-01 |
| Completed | Study of TRM-1(TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Small Cell Lung Cance Carcinoma, Non-Small-Cell Lung | Phase 2 | — |